Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL547978

O=S(=O)(O)C(F)(F)F.Sc1c(-c2ccccc2)c(-c2ccccc2)cc2ccccc12

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
RECQL P46063 1/20 0.43
GPR84 Q9NQS5 9/20 0.42
KDM4E B2RXH2 3/20 0.42
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
MPI P34949 1/20 0.39
ALOX5 P09917 1/20 0.38
PTPN1 P18031 1/20 0.38
PTGS2 P35354 1/20 0.36
ENPP1 P22413 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
LMNA P02545 1/20 0.34
CYP11B1 P15538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perflubutane SCHEMBL6029410 0.90 MEN1 (0.41) MEN1KMT2ARECQLGPR84KDM4E
SCHEMBL3680645 0.88 MEN1 (0.38) MEN1KMT2ARECQLGPR84KDM4E
SCHEMBL1041514 0.84 MEN1 (0.47) MEN1KMT2ARECQLGPR84KDM4E
SCHEMBL6063712 0.80 GPR84 (0.45) MEN1KMT2ARECQLGPR84KDM4E
Trifluoromethanesulfonic Acid SCHEMBL28266656 0.76 DNMT1 (0.41) MEN1KMT2AGPR84KDM4EHPGD
SCHEMBL8902918 0.74 CYP2D6 (0.51) MEN1KMT2ARECQLGPR84KDM4E
Trifluoromethanesulfonic Acid SCHEMBL27873665 0.73 PTPN1 (0.43) GPR84ALOX5PTPN1HSD17B1HSD17B2
Trifluoromethanesulfonic Acid SCHEMBL29049220 0.73 PTPN1 (0.47) HPGDALDH1A1PTPN1PTGS2ENPP1
Trifluoromethanesulfonic Acid SCHEMBL28025897 0.73 CA12 (0.45) MEN1KMT2AKDM4EHPGDALDH1A1
Biphenyl SCHEMBL27775705 0.73 PTPN1 (0.45) MEN1KMT2ARECQLKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100410-A1 IODINE-CONTAINING POLYMERIZABLE COMPOUND AND IODINE-CONTAINING POLYMER 三菱瓦斯化学株式会社 2026-05-15 WO disclosed
US-20250362597-A1 RESIST COMPOSITION AND RESIST FILM FORMING METHOD USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-11-27 US disclosed
US-20250321485-A1 RESIST AUXILIARY FILM COMPOSITION, AND PATTERN FORMING METHOD USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-10-16 US disclosed
US-20240369925-A1 RESIST AUXILIARY FILM COMPOSITION, AND PATTERN FORMING METHOD USING SAID COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-11-07 US disclosed
US-20240369924-A1 RESIST COMPOSITION AND RESIST FILM FORMING METHOD USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-11-07 US disclosed
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-26 US disclosed
US-20230096312-A1 RESIST COMPOSITION AND METHOD FOR USING RESIST COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-03-30 US disclosed
US-11572430-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-02-07 US disclosed
US-11480877-B2 Resist composition, method for forming resist pattern, and polyphenol compound used therein MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-10-25 US disclosed
US-11256170-B2 Compound, resist composition, and method for forming resist pattern using it MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-02-22 US disclosed
EP-1830228-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-09-05 EP disclosed
US-20070059632-A1 Method of manufacturing a semiconductor device MITSUBISHI GAS CHEMICAL CO., INC. (JP) 2007-03-15 US disclosed
EP-1739485-A1 RESIST COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-01-03 EP disclosed
EP-1666970-A1 COMPOUND FOR RESIST AND RADIATION-SENSITIVE COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-06-07 EP disclosed
US-20040191672-A1 Resist composition MITSUBISHI GAS CHEMICAL CO., LTD. (JP) 2004-09-30 US disclosed
EP-1443362-A2 Resist composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2004-08-04 EP disclosed
US-4358559-A CURABLE TO TACK-FREE ELASTOMERIC ARTICLES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-11-09 US disclosed
US-4343861-A Fluoroelastomer/polyepichlorohydrin elastomer articles MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-08-10 US disclosed
US-4293663-A SHAPING, CURING MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-10-06 US disclosed
US-4287322-A POLYPHENOL CURING AGENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11480877-B2 Resist composition, method for forming resist pattern, and polyphenol compound used therein SLC11A2, ABCC1, FBL MEN1 3872/4885KMT2A 2377/4885RECQL 3131/4885
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin SLC39A11, CROCC, TERB1 MEN1 1260/4885KMT2A 2526/4885RECQL 1670/4885
US-11256170-B2 Compound, resist composition, and method for forming resist pattern using it RDX, SLC11A2, FBL MEN1 3286/4885KMT2A 1321/4885RECQL 980/4885
US-11572430-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method C9, C5, C1R MEN1 1512/4885KMT2A 633/4885RECQL 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.